NCT07387237

Brief Summary

Multigene germeline panel test in gastric cancer patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 1, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 4, 2026

Completed
Last Updated

February 4, 2026

Status Verified

January 1, 2026

Enrollment Period

1.9 years

First QC Date

October 1, 2025

Last Update Submit

January 27, 2026

Conditions

Gastric Cancer (Diagnosis)Stomach Cancer

Keywords

Multigene Germeline Panel TestGastric Cancer

Outcome Measures

Primary Outcomes (1)

  • MGPT result

    positive vs negative

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults (≥18 years) with histologically confirmed gastric adenocarcinoma who underwent MGPT between 2020 and 2025

You may qualify if:

  • Eligible participants were adults (≥18 years) with histologically confirmed gastric adenocarcinoma who underwent MGPT between 2020 and 2025;
  • Ability to understand Portuguese and/or English;
  • Ability to provide valid informed consent.

You may not qualify if:

  • Patients without a definitive genetic report or with incomplete clinical data for key study variables were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unidade Local de Saúde do Alto Alentejo

Portalegre, Portugal

Location

Related Publications (1)

  • Mourato B, Cordeiro B, Costa Pinto F, Pratas N, Fronteira I, Areia M, Dinis R. Multigene Germline Panel Testing in Gastric Cancer Patients in a Portuguese Population. Cancer Med. 2026 Mar;15(3):e71732. doi: 10.1002/cam4.71732.

    PMID: 41853923DERIVED

MeSH Terms

Conditions

Stomach NeoplasmsDisease

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 1, 2025

First Posted

February 4, 2026

Study Start

September 20, 2023

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

February 4, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations

PT(1)